Nancy Jane Keuthen, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trichotillomania | 67 | 2023 | 177 | 14.060 |
Why?
|
| Obsessive-Compulsive Disorder | 35 | 2022 | 1489 | 3.370 |
Why?
|
| Self-Injurious Behavior | 21 | 2023 | 554 | 2.510 |
Why?
|
| Skin | 16 | 2018 | 4466 | 1.170 |
Why?
|
| Comorbidity | 26 | 2022 | 10551 | 0.950 |
Why?
|
| Psychiatric Status Rating Scales | 30 | 2017 | 6015 | 0.900 |
Why?
|
| Personality | 2 | 2016 | 552 | 0.800 |
Why?
|
| Habits | 2 | 2010 | 146 | 0.690 |
Why?
|
| Anxiety Disorders | 10 | 2017 | 2714 | 0.680 |
Why?
|
| Stereotypic Movement Disorder | 7 | 2010 | 30 | 0.650 |
Why?
|
| Depressive Disorder | 12 | 2014 | 3726 | 0.620 |
Why?
|
| Self Mutilation | 2 | 2016 | 58 | 0.620 |
Why?
|
| Compulsive Personality Disorder | 1 | 2017 | 48 | 0.580 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 9 | 2019 | 1988 | 0.550 |
Why?
|
| Compulsive Behavior | 1 | 2016 | 117 | 0.510 |
Why?
|
| Citalopram | 2 | 2009 | 402 | 0.510 |
Why?
|
| Psychotropic Drugs | 6 | 2015 | 883 | 0.500 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2015 | 36 | 0.500 |
Why?
|
| Adult | 80 | 2022 | 219994 | 0.410 |
Why?
|
| Severity of Illness Index | 26 | 2022 | 15840 | 0.410 |
Why?
|
| Depression | 10 | 2022 | 8044 | 0.390 |
Why?
|
| Personality Disorders | 2 | 2015 | 721 | 0.370 |
Why?
|
| Thiophenes | 1 | 2015 | 587 | 0.350 |
Why?
|
| Impulsive Behavior | 3 | 2022 | 346 | 0.350 |
Why?
|
| Self Report | 4 | 2020 | 3711 | 0.330 |
Why?
|
| Female | 93 | 2023 | 391270 | 0.320 |
Why?
|
| Anxiety | 7 | 2022 | 4538 | 0.320 |
Why?
|
| Depressive Disorder, Major | 4 | 2023 | 4744 | 0.310 |
Why?
|
| Psychometrics | 11 | 2022 | 3051 | 0.310 |
Why?
|
| Executive Function | 1 | 2017 | 1374 | 0.310 |
Why?
|
| Body Dysmorphic Disorders | 3 | 2016 | 243 | 0.300 |
Why?
|
| Disability Evaluation | 2 | 2014 | 1826 | 0.290 |
Why?
|
| Personality Inventory | 10 | 2015 | 1018 | 0.290 |
Why?
|
| Interpersonal Relations | 2 | 2014 | 1428 | 0.290 |
Why?
|
| Meditation | 1 | 2010 | 251 | 0.290 |
Why?
|
| Corpus Striatum | 3 | 2017 | 1233 | 0.280 |
Why?
|
| Information Dissemination | 1 | 2015 | 1131 | 0.270 |
Why?
|
| Cross-Cultural Comparison | 4 | 2016 | 633 | 0.270 |
Why?
|
| Male | 76 | 2023 | 359744 | 0.270 |
Why?
|
| Adolescent | 40 | 2022 | 87810 | 0.250 |
Why?
|
| Humans | 105 | 2023 | 760621 | 0.250 |
Why?
|
| Sertraline | 1 | 2006 | 208 | 0.240 |
Why?
|
| Emotions | 6 | 2012 | 2734 | 0.240 |
Why?
|
| Israel | 3 | 2016 | 722 | 0.240 |
Why?
|
| Hospitals, General | 3 | 2007 | 795 | 0.240 |
Why?
|
| Fluoxetine | 5 | 2004 | 733 | 0.230 |
Why?
|
| Affect | 3 | 2009 | 1480 | 0.230 |
Why?
|
| Behavior Therapy | 13 | 2012 | 868 | 0.230 |
Why?
|
| Jews | 2 | 2016 | 364 | 0.220 |
Why?
|
| Factor Analysis, Statistical | 5 | 2015 | 998 | 0.220 |
Why?
|
| Middle Aged | 48 | 2022 | 220352 | 0.220 |
Why?
|
| Substance-Related Disorders | 2 | 2017 | 4371 | 0.220 |
Why?
|
| Arabs | 2 | 2016 | 187 | 0.220 |
Why?
|
| Quality of Life | 5 | 2022 | 13308 | 0.210 |
Why?
|
| Age of Onset | 5 | 2019 | 3301 | 0.210 |
Why?
|
| Young Adult | 19 | 2022 | 58741 | 0.200 |
Why?
|
| Students | 5 | 2014 | 1730 | 0.200 |
Why?
|
| Health Surveys | 5 | 2010 | 4063 | 0.200 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 3701 | 0.200 |
Why?
|
| Internet | 5 | 2009 | 3078 | 0.190 |
Why?
|
| Population Surveillance | 1 | 2010 | 2608 | 0.170 |
Why?
|
| Cerebellum | 1 | 2006 | 1496 | 0.160 |
Why?
|
| Smoking Cessation | 5 | 2004 | 2064 | 0.150 |
Why?
|
| Dermatology | 2 | 2022 | 914 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 36290 | 0.150 |
Why?
|
| Learning | 1 | 2007 | 1739 | 0.140 |
Why?
|
| Mental Disorders | 6 | 2022 | 6796 | 0.140 |
Why?
|
| Reproducibility of Results | 9 | 2022 | 20080 | 0.130 |
Why?
|
| Prevalence | 10 | 2023 | 15687 | 0.130 |
Why?
|
| Paroxetine | 2 | 1997 | 182 | 0.120 |
Why?
|
| Tourette Syndrome | 1 | 2017 | 394 | 0.120 |
Why?
|
| Tobacco Use Disorder | 1 | 2000 | 700 | 0.120 |
Why?
|
| Reward | 1 | 2021 | 963 | 0.120 |
Why?
|
| Skin Diseases | 3 | 2012 | 1089 | 0.120 |
Why?
|
| Family | 2 | 2016 | 3189 | 0.120 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 5761 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2017 | 520 | 0.110 |
Why?
|
| Menstrual Cycle | 1 | 1997 | 536 | 0.110 |
Why?
|
| Social Adjustment | 2 | 2009 | 632 | 0.110 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 340 | 0.100 |
Why?
|
| Body Image | 4 | 2002 | 635 | 0.100 |
Why?
|
| Combined Modality Therapy | 7 | 2010 | 8552 | 0.100 |
Why?
|
| Treatment Outcome | 12 | 2017 | 65017 | 0.100 |
Why?
|
| Inservice Training | 1 | 2015 | 375 | 0.100 |
Why?
|
| Brain | 6 | 2022 | 26951 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17790 | 0.100 |
Why?
|
| South Africa | 1 | 2017 | 1821 | 0.100 |
Why?
|
| Neuropsychological Tests | 8 | 2017 | 7021 | 0.100 |
Why?
|
| Dizziness | 1 | 1994 | 257 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2009 | 10827 | 0.090 |
Why?
|
| Adaptation, Psychological | 4 | 2022 | 2628 | 0.090 |
Why?
|
| Culture | 1 | 2014 | 622 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2022 | 8555 | 0.090 |
Why?
|
| Somatoform Disorders | 3 | 2002 | 423 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 1996 | 622 | 0.090 |
Why?
|
| Psychomotor Performance | 4 | 2007 | 1878 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2020 | 1940 | 0.090 |
Why?
|
| Stress, Psychological | 4 | 2016 | 4446 | 0.090 |
Why?
|
| Problem Solving | 2 | 2005 | 440 | 0.090 |
Why?
|
| Single-Blind Method | 2 | 2017 | 1578 | 0.080 |
Why?
|
| Double-Blind Method | 7 | 2017 | 12427 | 0.080 |
Why?
|
| Sex Factors | 3 | 2016 | 10547 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2852 | 0.080 |
Why?
|
| Weight Gain | 1 | 1999 | 2347 | 0.080 |
Why?
|
| Marital Status | 1 | 2010 | 433 | 0.080 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1175 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 359 | 0.070 |
Why?
|
| Visual Perception | 2 | 2005 | 1374 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 39261 | 0.070 |
Why?
|
| Regression Analysis | 4 | 2010 | 6360 | 0.070 |
Why?
|
| Memory | 3 | 2005 | 2179 | 0.070 |
Why?
|
| Aged | 12 | 2019 | 169152 | 0.070 |
Why?
|
| Nail Biting | 1 | 2005 | 3 | 0.070 |
Why?
|
| Hypnosis | 2 | 2010 | 82 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15289 | 0.070 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 894 | 0.060 |
Why?
|
| Cerebellar Cortex | 1 | 2006 | 107 | 0.060 |
Why?
|
| Data Collection | 1 | 2014 | 3315 | 0.060 |
Why?
|
| Child | 12 | 2022 | 79806 | 0.060 |
Why?
|
| Massachusetts | 4 | 2007 | 8803 | 0.060 |
Why?
|
| Spatial Behavior | 1 | 2005 | 88 | 0.060 |
Why?
|
| Reference Values | 3 | 2001 | 4925 | 0.060 |
Why?
|
| Residential Treatment | 1 | 2005 | 107 | 0.060 |
Why?
|
| Tic Disorders | 1 | 2005 | 136 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3465 | 0.060 |
Why?
|
| Organ Size | 2 | 2020 | 2254 | 0.060 |
Why?
|
| Reaction Time | 2 | 2007 | 2075 | 0.060 |
Why?
|
| Placebos | 2 | 2006 | 1668 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 8950 | 0.060 |
Why?
|
| Smoking | 1 | 2000 | 9073 | 0.060 |
Why?
|
| Attention | 6 | 2008 | 2387 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7806 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2015 | 22053 | 0.050 |
Why?
|
| Self Concept | 3 | 2009 | 1039 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2012 | 2062 | 0.050 |
Why?
|
| Self Care | 1 | 2007 | 793 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2008 | 2417 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 489 | 0.050 |
Why?
|
| Logistic Models | 1 | 2015 | 13314 | 0.050 |
Why?
|
| Observer Variation | 1 | 2006 | 2601 | 0.040 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 453 | 0.040 |
Why?
|
| Psychiatry | 1 | 2012 | 1689 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2014 | 9287 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2006 | 2698 | 0.040 |
Why?
|
| Motivation | 2 | 2000 | 1993 | 0.040 |
Why?
|
| Hair | 1 | 2023 | 497 | 0.040 |
Why?
|
| Personality Assessment | 1 | 2001 | 650 | 0.040 |
Why?
|
| Fluvoxamine | 1 | 1999 | 78 | 0.040 |
Why?
|
| United States | 4 | 2017 | 72461 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2008 | 1717 | 0.040 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2019 | 148 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 211 | 0.040 |
Why?
|
| Models, Psychological | 3 | 2012 | 827 | 0.040 |
Why?
|
| Stereotyped Behavior | 2 | 2008 | 135 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 14495 | 0.040 |
Why?
|
| Wounds and Injuries | 2 | 2018 | 2477 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2018 | 264 | 0.040 |
Why?
|
| Sickness Impact Profile | 1 | 1998 | 298 | 0.030 |
Why?
|
| Interdisciplinary Communication | 2 | 2012 | 934 | 0.030 |
Why?
|
| Delusions | 1 | 1999 | 298 | 0.030 |
Why?
|
| Hospitalization | 2 | 2007 | 10790 | 0.030 |
Why?
|
| Premenstrual Syndrome | 1 | 1997 | 107 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 18416 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2016 | 2362 | 0.030 |
Why?
|
| Germany | 3 | 2002 | 873 | 0.030 |
Why?
|
| Psychological Tests | 2 | 1995 | 639 | 0.030 |
Why?
|
| Mental Recall | 2 | 2005 | 1206 | 0.030 |
Why?
|
| Clomipramine | 1 | 1994 | 54 | 0.030 |
Why?
|
| Pregnancy | 1 | 1997 | 29749 | 0.030 |
Why?
|
| Drug Therapy | 2 | 2008 | 504 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 1997 | 552 | 0.030 |
Why?
|
| Hippocampus | 1 | 2007 | 3738 | 0.030 |
Why?
|
| Risk Factors | 3 | 2017 | 74359 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2326 | 0.030 |
Why?
|
| Cross-Sectional Studies | 5 | 2012 | 25942 | 0.030 |
Why?
|
| Family Health | 1 | 1998 | 1257 | 0.030 |
Why?
|
| Auditory Perception | 1 | 1978 | 580 | 0.030 |
Why?
|
| Speech | 1 | 1978 | 550 | 0.030 |
Why?
|
| Space Perception | 1 | 1996 | 464 | 0.030 |
Why?
|
| Vision, Ocular | 1 | 1996 | 454 | 0.030 |
Why?
|
| Internationality | 1 | 2018 | 1004 | 0.030 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 1996 | 303 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 24123 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 2128 | 0.020 |
Why?
|
| London | 1 | 2012 | 234 | 0.020 |
Why?
|
| Antidepressive Agents | 2 | 2005 | 2890 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1998 | 1535 | 0.020 |
Why?
|
| Twins | 1 | 2012 | 339 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 12965 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2009 | 236 | 0.020 |
Why?
|
| Universities | 1 | 2014 | 992 | 0.020 |
Why?
|
| Recurrence | 2 | 1999 | 8482 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 4555 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 36060 | 0.020 |
Why?
|
| Defense Mechanisms | 1 | 2009 | 180 | 0.020 |
Why?
|
| Mood Disorders | 2 | 2008 | 1124 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2010 | 42063 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2008 | 41335 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2009 | 469 | 0.020 |
Why?
|
| Friends | 1 | 2009 | 150 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 58995 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 2 | 2007 | 810 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1650 | 0.020 |
Why?
|
| Achievement | 1 | 2009 | 289 | 0.020 |
Why?
|
| Cicatrix | 1 | 2012 | 782 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2010 | 410 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14660 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1990 | 459 | 0.020 |
Why?
|
| Psychopathology | 1 | 2008 | 429 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 3448 | 0.020 |
Why?
|
| Caudate Nucleus | 2 | 1997 | 389 | 0.020 |
Why?
|
| Incidence | 2 | 2002 | 21392 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1500 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 3061 | 0.020 |
Why?
|
| Time Factors | 3 | 2020 | 40165 | 0.010 |
Why?
|
| Periodicity | 1 | 2005 | 348 | 0.010 |
Why?
|
| Awareness | 1 | 2008 | 646 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2005 | 6238 | 0.010 |
Why?
|
| Alopecia | 1 | 2008 | 414 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2007 | 758 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3164 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1998 | 8056 | 0.010 |
Why?
|
| Patients | 1 | 2008 | 906 | 0.010 |
Why?
|
| Cues | 1 | 2007 | 867 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2010 | 2029 | 0.010 |
Why?
|
| Volition | 1 | 1999 | 62 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 18137 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1998 | 80372 | 0.010 |
Why?
|
| Cognition | 1 | 1996 | 6957 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2012 | 4783 | 0.010 |
Why?
|
| Mass Screening | 1 | 2012 | 5423 | 0.010 |
Why?
|
| Phonetics | 1 | 1978 | 198 | 0.010 |
Why?
|
| Putamen | 1 | 1997 | 291 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1997 | 249 | 0.010 |
Why?
|
| Haloperidol | 1 | 1997 | 389 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1997 | 622 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1990 | 3976 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 1996 | 335 | 0.010 |
Why?
|
| Parents | 1 | 2008 | 3549 | 0.010 |
Why?
|
| Mental Health | 1 | 2006 | 3213 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 1996 | 749 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1990 | 6915 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1996 | 2253 | 0.010 |
Why?
|
| Alcoholism | 1 | 1999 | 1961 | 0.000 |
Why?
|
| Animals | 1 | 1998 | 167963 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1990 | 2781 | 0.000 |
Why?
|
| Algorithms | 1 | 1997 | 13981 | 0.000 |
Why?
|